(P911) Porsche - Overview
Stock: Sports Cars, SUVs, Financing, Leasing, Insurance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.25% |
| Yield on Cost 5y | 3.04% |
| Yield CAGR 5y | 51.23% |
| Payout Consistency | 98.8% |
| Payout Ratio | 16.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.3% |
| Relative Tail Risk | -8.17% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.95 |
| Alpha | -33.07 |
| Character TTM | |
|---|---|
| Beta | 0.302 |
| Beta Downside | 0.309 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.19% |
| CAGR/Max DD | -0.44 |
Description: P911 Porsche January 29, 2026
Dr. Ing. h.c. F. Porsche AG (XETRA:P911) is a German-based automotive and financial-services group that designs, manufactures and sells passenger vehicles while also providing leasing, dealer financing, insurance brokerage and mobility solutions across Europe, North America, China and other markets. The company, a subsidiary of Porsche Holding Stuttgart GmbH, was established in 2009 after renaming from Porsche Fünfte Vermögensverwaltung AG and is headquartered in Stuttgart.
In the most recent fiscal year (2023) Porsche reported €35.8 billion in total revenue, a 4.2 % YoY increase driven primarily by a 12 % rise in electric-vehicle (EV) sales, which now represent 18 % of its global volume. The automotive segment delivered an EBIT margin of 9.5 %, while the financial-services arm contributed €1.2 billion in net profit, reflecting a 7 % uplift from higher leasing volumes and rising interest-rate spreads. As of Q1 2024, the company’s order backlog stands at €9.6 billion, indicating robust demand despite a tightening credit environment.
Key economic and sector drivers include the accelerating EU push for zero-emission vehicles (targeting 30 % EV sales by 2030), which underpins Porsche’s investment in battery technology and platform electrification, and the current high-interest-rate cycle that both raises financing income and pressures consumer borrowing capacity. Supply-chain resilience remains a material risk; however, Porsche’s diversified sourcing strategy has limited production disruptions to under 2 % of output in 2023.
For a deeper quantitative assessment, see the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 952.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.05 > 1.0 |
| NWC/Revenue: 14.15% < 20% (prev 14.71%; Δ -0.56% < -1%) |
| CFO/TA 0.09 > 3% & CFO 4.85b > Net Income 952.0m |
| Net Debt (6.23b) to EBITDA (6.55b): 0.95 < 3 |
| Current Ratio: 1.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (909.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 16.45% > 18% (prev 0.26%; Δ 1619 % > 0.5%) |
| Asset Turnover: 72.64% > 50% (prev 74.80%; Δ -2.16% > 0%) |
| Interest Coverage Ratio: 4.13 > 6 (EBITDA TTM 6.55b / Interest Expense TTM 358.0m) |
Altman Z'' 2.60
| A: 0.10 (Total Current Assets 21.00b - Total Current Liabilities 15.57b) / Total Assets 53.59b |
| B: 0.34 (Retained Earnings 17.99b / Total Assets 53.59b) |
| C: 0.03 (EBIT TTM 1.48b / Avg Total Assets 52.84b) |
| D: 0.62 (Book Value of Equity 19.22b / Total Liabilities 30.84b) |
| Altman-Z'' Score: 2.60 = A |
Beneish M -2.40
| DSRI: 1.24 (Receivables 2.49b/2.04b, Revenue 38.38b/38.96b) |
| GMI: 1.61 (GM 16.45% / 26.44%) |
| AQI: 0.93 (AQ_t 0.32 / AQ_t-1 0.34) |
| SGI: 0.99 (Revenue 38.38b / 38.96b) |
| TATA: -0.07 (NI 952.0m - CFO 4.85b) / TA 53.59b) |
| Beneish M-Score: -2.40 (Cap -4..+1) = BBB |
What is the price of P911 shares?
Over the past week, the price has changed by -3.71%, over one month by -14.69%, over three months by -13.74% and over the past year by -30.82%.
Is P911 a buy, sell or hold?
What are the forecasts/targets for the P911 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 45.6 | 14.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 37.1 | -6.5% |
P911 Fundamental Data Overview February 03, 2026
P/E Trailing = 39.625
P/E Forward = 19.305
P/S = 0.9781
P/B = 1.6616
P/EG = 1.228
Revenue TTM = 38.38b EUR
EBIT TTM = 1.48b EUR
EBITDA TTM = 6.55b EUR
Long Term Debt = 6.47b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.96b EUR (from shortTermDebt, last quarter)
Debt = 11.43b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.23b EUR (from netDebt column, last quarter)
Enterprise Value = 43.77b EUR (37.54b + Debt 11.43b - CCE 5.20b)
Interest Coverage Ratio = 4.13 (Ebit TTM 1.48b / Interest Expense TTM 358.0m)
EV/FCF = 20.23x (Enterprise Value 43.77b / FCF TTM 2.16b)
FCF Yield = 4.94% (FCF TTM 2.16b / Enterprise Value 43.77b)
FCF Margin = 5.64% (FCF TTM 2.16b / Revenue TTM 38.38b)
Net Margin = 2.48% (Net Income TTM 952.0m / Revenue TTM 38.38b)
Gross Margin = 16.45% ((Revenue TTM 38.38b - Cost of Revenue TTM 32.07b) / Revenue TTM)
Gross Margin QoQ = -1.03% (prev 16.15%)
Tobins Q-Ratio = 0.82 (Enterprise Value 43.77b / Total Assets 53.59b)
Interest Expense / Debt = 3.13% (Interest Expense 358.0m / Debt 11.43b)
Taxrate = 31.22% (1.63b / 5.23b)
NOPAT = 1.02b (EBIT 1.48b * (1 - 31.22%))
Current Ratio = 1.35 (Total Current Assets 21.00b / Total Current Liabilities 15.57b)
Debt / Equity = 0.50 (Debt 11.43b / totalStockholderEquity, last quarter 22.63b)
Debt / EBITDA = 0.95 (Net Debt 6.23b / EBITDA 6.55b)
Debt / FCF = 2.88 (Net Debt 6.23b / FCF TTM 2.16b)
Total Stockholder Equity = 23.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.80% (Net Income 952.0m / Total Assets 53.59b)
RoE = 4.09% (Net Income TTM 952.0m / Total Stockholder Equity 23.26b)
RoCE = 4.97% (EBIT 1.48b / Capital Employed (Equity 23.26b + L.T.Debt 6.47b))
RoIC = 3.38% (NOPAT 1.02b / Invested Capital 30.10b)
WACC = 5.89% (E(37.54b)/V(48.97b) * Re(7.03%) + D(11.43b)/V(48.97b) * Rd(3.13%) * (1-Tc(0.31)))
Discount Rate = 7.03% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.14%
[DCF Debug] Terminal Value 86.58% ; FCFF base≈1.92b ; Y1≈1.97b ; Y5≈2.19b
Fair Price DCF = 129.5 (EV 65.20b - Net Debt 6.23b = Equity 58.98b / Shares 455.5m; r=5.90% [WACC]; 5y FCF grow 2.43% → 2.90% )
EPS Correlation: -84.36 | EPS CAGR: -31.72% | SUE: -2.00 | # QB: 0
Revenue Correlation: -3.26 | Revenue CAGR: -3.68% | SUE: -0.74 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=2.29 | Chg30d=-0.092 | Revisions Net=-3 | Growth EPS=+412.4% | Growth Revenue=+0.8%